Detalhe da pesquisa
1.
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Ann Oncol
; 28(12): 3000-3008, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950372
2.
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 32(12): 1520-1536, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500044
3.
What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients.
Br J Cancer
; 110(10): 2420-6, 2014 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24736584
4.
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Ann Oncol
; 30(2): 344, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741569
5.
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)â.
ESMO Open
; 6(5): 100250, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562750
6.
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.
Br J Cancer
; 102(7): 1106-12, 2010 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20234360
7.
Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.
J Clin Oncol
; 21(15): 2974-81, 2003 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12885818
8.
A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma.
Br J Cancer
; 89(10): 1901-5, 2003 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-14612900